A chilling account from a medical expert involves a ballerina from the New York City Ballet. She had a small, contained tumor. A biopsy was performed.
Video below article ⬇️⬇️⬇️
Shortly after, she called in distress: “They biopsied it, and now there are little tumors everywhere.”
This is the critical risk many aren’t warned about. The body often walls off a tumor with a protective fibrin sheath. The biopsy needle punctures that seal, potentially unleashing cancer cells and, as evidence suggests, almost guaranteeing the acceleration of metastasis.
The medical establishment justifies this by stating an absolute need for a “histological diagnosis.” A pathologist must name it—”Yes, this is a ductal carcinoma”—to set the treatment pathway.
But is this for the patient’s benefit, or is it part of a “sales technique”?
That specific diagnosis justifies specific, FDA-approved, insurance-covered drugs. It creates the protocol. Yet, emerging research suggests a devastating sequence:
- Biopsy or Surgery? You may be almost guaranteeing metastasis.
- Add High-Dose Chemo? You are still on a path to metastasis.
- Add Radiation? The outcome remains the same.
The tragic irony? These aggressive interventions often achieve a short-term reduction of the primary tumor, creating the illusion of “remission.”
Only for the cancer to return, more aggressively, often within months.
The system is focused on winning the battle against the primary tumor, potentially at the cost of losing the war against metastatic disease.
[Via: @newstart_2024]